Facetten
Zugriff
Einrichtung
Medientyp
- Text 9
Karte
Erscheinungsjahr
Autor/in
- Kantarjian, Hagop M 9
- Kim, Dong-Wook
- Gambacorti-Passerini, Carlo 8
- Cortes, Jorge E 7
- Leip, Eric 7
- alle zeigen
Sprache
- Englisch 9
9 Einträge gefunden
-
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
- Gambacorti-Passerini, Carlo
- Cortes, Jorge E
- Lipton, Jeff H
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Schafhausen, Philippe
- Crescenzo, Rocco
-
-
-
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
- Brümmendorf, Tim H
- Cortes, Jorge E
- Khoury, Hanna J
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Schafhausen, Philippe
- Conlan, Maureen G
-
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
- Gambacorti-Passerini, Carlo
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Khoury, Hanna J
- Turkina, Anna G
- Brümmendorf, Tim H
- Matczak, Ewa
-
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up
- Gambacorti-Passerini, Carlo
- Brümmendorf, Tim H
- Kim, Dong-Wook
- Turkina, Anna G
- Masszi, Tamas
- Assouline, Sarit
- Durrant, Simon
-
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors
- Kantarjian, Hagop M
- Cortes, Jorge E
- Kim, Dong-Wook
- Khoury, H Jean
- Brümmendorf, Tim H
- Porkka, Kimmo
- Martinelli, Giovanni
-
-